BDF Gestion’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
Other funds holding MRNA
TP
BDF Gestion's MRNA Position: Q2 2026 in Review
BDF Gestion reduced its Moderna (MRNA) stake by 10% in Q2 2026, selling an estimated $101K and leaving 17,370 shares worth $1.86M. The position accounts for 0.25% of the portfolio, ranked #107.
BDF Gestion first reported a position in MRNA in Q1 2025 and has held it in 6 quarters since. 782 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.
- BDF Gestion held 17,370 shares of Moderna worth $1.86M as of Q2 2026.
- BDF Gestion sold 1,953 Moderna shares in Q2 2026, an estimated $101K.
- Moderna made up 0.25% of BDF Gestion's portfolio in Q2 2026, its #107 holding.
- BDF Gestion first reported a position in Moderna in Q1 2025 and has held it in 6 quarters since.
- 782 funds tracked by Wall St. Rank held Moderna as of Q2 2026.
Based on BDF Gestion's 13F filing for Q2 2026, filed 7 Jul 2026.